ASCVD and rapamycin

[ZZZZ]

In high doses vs. intermittent dosing, I understand rapamycin could potentially cause dyslipidemia and insulin resistance. What is the research on plaque regression and stabilization and any difference vs. traditional therapies. Is the rapamycin mode of action for positive benefits reduced inflammation? Other modes of action if any?

[A_User]

@ZZZZ

What is the research on plaque regression and stabilization and any difference vs. traditional therapies

No evidence for it.